Acquisitions - Summary of Purchase Price Allocation for Acquired Identifiable Assets, Liabilities Assumed and Goodwill (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands		Apr. 10, 2023	Apr. 10, 2025	Jun. 29, 2024	Apr. 10, 2024	Dec. 30, 2023	Dec. 31, 2022
Liabilities assumed:
Total goodwill				$ 241,872		$ 243,441	$ 155,998
Weekend Health, Inc. d/b/a Sequence
Total consideration:
Cash paid at closing		$ 64,217
Cash paid on April 10, 2024					$ 16,000
Aggregated merger consideration		132,000
Assets acquired:
Cash		25,800
Weekend Health, Inc. d/b/a Sequence | Purchase Price Allocation
Total consideration:
Cash paid at closing		64,217
Cash paid on April 10, 2024					$ 16,000
Payments in Cash to Acquire Businesses, Total		92,637
Less stock-based compensation expense attributable to post combination vesting		(3,882)
Aggregated merger consideration		121,698
Assets acquired:
Cash		25,776
Prepaid expenses and other current assets		2,220
Property, plant and equipment		34
Intangible assets		7,222
Total assets acquired		35,252
Liabilities assumed:
Accounts payable		70
Accrued liabilities		14
Deferred revenue		1,300
Deferred tax liability		1,912
Total liabilities assumed		3,296
Net assets acquired		31,956
Total goodwill		$ 89,742
Weekend Health, Inc. d/b/a Sequence | Common Stock
Total consideration:
Common shares issued		7,996
Stock price as of April 10, 2023		$ 4.34
Weekend Health, Inc. d/b/a Sequence | Common Stock | Purchase Price Allocation
Total consideration:
Common shares issued		7,996
Stock price as of April 10, 2023	[1]	$ 4.12
Total stock issuance purchase price	[1]	$ 32,943
Weekend Health, Inc. d/b/a Sequence | Scenario Forecast
Total consideration:
Cash to be paid on April 10, 2025			$ 16,000
Weekend Health, Inc. d/b/a Sequence | Scenario Forecast | Purchase Price Allocation
Total consideration:
Cash to be paid on April 10, 2025	[2]		$ 12,420

[1] Represents the fair value of the shares transferred to the sellers as Merger Consideration, based on the number of shares to be issued, 7,996, multiplied by the closing price of the Company’s shares on April 10, 2023 of $4.12 per share.

[2] Reflects $16,000 of cash payable on April 10, 2025 as Merger Consideration discounted using the Company’s weighted average cost of debt.